A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Edema, Cardiac
Interventions
DRUG

OPC-41061(Tolvaptan)

0, 15mg of OPC-41061 per day for 7days p.o. administration

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY